However, it typically expresses EBV, demonstrated by EBER-ISH positivity, and may retain B-cell markers like CD20 or CD79a, which are usually absent or only weakly expressed in plasmacytomas [7,8]. The gene discussed is CD79A; the disease is plasmacytoma.